Genome & Company

Genome & Company is a biopharmaceutical firm based in Suwon, South Korea, that develops immuno-oncology and microbiome-based therapeutics, novel immune checkpoint inhibitors, and consumer health products. The enterprise utilizes its GNOCLE platform, which integrates real-world clinical data and multi-omics analytics, to discover drug candidates targeting cancer, skin diseases, and central nervous system disorders. Operating as a publicly traded entity on the KONEX exchange with a market capitalization of approximately $280 million, the firm collaborates on pharmaceutical development with major industry players including Pfizer, Merck, and LG Chem. To expand its contract development and manufacturing organization capabilities, the business acquired a 60 percent stake in United States-based List Labs for $27 million in 2021 without issuing new shares. Genome & Company was established in September 2015 by co-founders Jisoo Pae and Hansoo Park.